ARTSAVIT
ARTSaVIT is a biopharmaceuticals company developing a cancer drug.
ARTSAVIT
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
Yavne, HaMerkaz, Israel
Country:
Israel
Total Employee:
1+
Status:
Active
Total Funding:
6.3 M USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Promedstem
Promedstem is a company a developing a stem cell product.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Arkin Bio Ventures
Arkin Bio Ventures investment in Series A - ARTSaVIT
M Ventures
M Ventures investment in Series A - ARTSaVIT
Pontifax
Pontifax investment in Series A - ARTSaVIT
More informations about "ARTSaVIT"
ARTSaVIT - Crunchbase Company Profile & Funding
Organization. ARTSaVIT . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About. ... ARTSaVIT is a biopharmaceuticals company developing a cancer drug. Lists Featuring This Company. Edit Lists Featuring This Company Section. …See details»
Artsavit Company Profile 2024: Valuation, Funding & Investors
Artsavit General Information Description. Operator of drug discovery platform intended to provide treatment for cancer. The company's platform offers a drug that activates a controlled cell-killer …See details»
ARTSaVIT - Funding, Financials, Valuation & Investors - Crunchbase
ARTSaVIT is a biopharmaceuticals company developing a cancer drug. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How …See details»
Artsavit Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Artsavit Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
ARTSaVIT - Products, Competitors, Financials, Employees, …
ARTSaVIT Ltd. Completes $6.3 Million Series A Financing. Jan 5, 2017. 05/01/2017 · Israel · Pharma & Biotech · Arkin Bio Ventures , Carmel Innovation , Merck Ventures , Pontifax Israeli …See details»
ARTSaVIT Ltd - Company Profile and News - Bloomberg Markets
Company profile page for ARTSaVIT Ltd including stock price, company news, executives, board members, and contact informationSee details»
ARTSaVIT - Contacts, Employees, Board Members, Advisors
ARTSaVIT is a biopharmaceuticals company developing a cancer drug.See details»
ARTSaVIT - Company Profile - Tracxn
ARTSaVIT - Apoptosis mechanism activating protein for cancer. This company is not active anymore. Raised a total funding of $6.3M over 1 round from 3 investors. ARTSaVIT has 2795 …See details»
ARTSaVIT Ltd. - BioCentury Company Profiles - BCIQ
Jan 20, 2017 ARTSaVIT Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
ARTSaVIT Ltd. Asset Profile | Preqin
Based in Haifa, Israel, ARTSaVIT Ltd. is a healthcare company that develops cancer apoptosis treatments. Current Investors Pontifax Venture Capital, M Ventures, Arkin Holdings Request a …See details»
Cancer Fighter ARTSaVIT Raises $6.3M - nocamels.com
January 4, 2017 | Israeli cancer apoptosis company ARTSaVIT LTD. announced today that it has completed a $6.3 million Series A round of financing led by Arkin Bio Ventures and Pontifax, …See details»
ARTSaVIT - Foreign Startup | Startup Nation Finder
Jan 4, 2017 Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. Send …See details»
Cancer treatment co ARTSaVIT raises $6.3m - Globes
ARTSaVIT, a company developing a cancer drug, has completed a $6.3 financing round. The company is slated to enter the Merck Ventures incubator in Yavne operating under Inter-Lab, …See details»
ARTSaVIT - Crunchbase
ARTSaVIT is a biopharmaceuticals company developing a cancer drug.See details»
ARTSaVIT - Lifecycle | Startup Nation Finder
Find out more about ARTSaVIT's lifecycle at SNC Finder! Explore the company's timeline including investment rounds, public offerings, M&A and more.See details»
ARTSaVIT Ltd. Completes $6.3 Million Series A Financing
YAVNE, Israel, January 5, 2016 - Israeli cancer apoptosis company ARTSaVIT LTD announced today that it has completed a $6.3 million Series A round of financing led by Arkin Bio …See details»
סטארט-אפ ישראלי שמפתח תרופה לסרטן גייס 6.3 מיליון דולר - גלובס
Jan 4, 2017 חברת ARTSaVIT, שמפתחת תרופה ל סרטן, השלימה גיוס של 6.3 מיליון דולר והיא צפויה להשתלב בחממת Merck Ventures ביבנה, הפועלת ...See details»
Artsavit Ltd., Haifa, Israel - North Data
Artsavit Ltd., Haifa, Israel, Registrar of Companies 515042539: Network, Financial informationSee details»
Series A - ARTSaVIT - 2017-01-04 - Crunchbase
Organization Name . ARTSaVIT . Announced Date Jan 4, 2017; Funding Type ...See details»
ARTSaVIT Management Team - CB Insights
Explore {ARTSaVIT's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»